A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS

This study has been completed.

Study NCT00000674 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: November 2, 1999 Last Updated: June 23, 2005 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Toxoplasmosis, Cerebral
HIV Infections

Additional conditions recognized in this trial

Acquired Immunodeficiency Syndrome
Communicable Diseases
Encephalitis
Infection
Toxoplasmosis

Interventions listed in this trial

Pyrimethamine
Leucovorin calcium
Clindamycin

Additional drug interventions recognized in this trial

Clindamycin-2-phosphate
Leucovorin

More general drug interventions related to this trial

Anti-Bacterial Agents
Anti-Infective Agents
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Folic Acid Antagonists
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protein Synthesis Inhibitors
Therapeutic Uses
Vitamin B Complex
Vitamins

Sponsors listed in this trial

Upjohn
National Institute of Allergy and Infectious Diseases (NIAID)
Glaxo Wellcome

Back to top of Main Content